Initiator Pharma A/S

Initiator Pharma A/S OCF Margin

Operating Cash Flow Margin of Initiator Pharma A/S (INIT.ST) as of Nov 3, 2026.

OCF Margin

-

Last updated:

Operating Cash Flow Margin of Initiator Pharma A/S is 2026 - . Operating Cash Flow Margin of Initiator Pharma A/S was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Initiator Pharma A/S Stock analysis

What does Initiator Pharma A/S do? Initiator Pharma A/S is a clinical-stage biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. The company develops novel therapeutics targeting monoamine reuptake transporters for central nervous system disorders, with a focus on erectile dysfunction treatments. Initiator Pharma A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Initiator Pharma A/S stock

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Initiator Pharma A/S since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Initiator Pharma A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Initiator Pharma A/S

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Initiator Pharma A/S